Sotera Health sees FY25 adjusted EPS 70c-76c, consensus 78c

Sotera Health (SHC) is providing its full-year 2025 outlook: Net revenues growth in the range of 4.0% to 6.0%, on a constant currency basis, Foreign currency headwind to net revenues of approximately 2.25%, Adjusted EBITDA growth in the range of 4.5% to 6.5%, on a constant currency basis, Foreign currency headwind to Adjusted EBITDA of approximately 2.50%, Interest expense in the range of $155 million to $165 million, Tax rate applicable to Adjusted Net Income in the range of 33.0% to 35.0%, Adjusted EPS in the range of $0.70 to $0.76, A weighted-average fully diluted share count in the range of 286 million to 287 million shares, Capital expenditures in the range of $190 million to $210 million,